Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 1081 AL 1095

The effect of cognitive stimulation therapy (CST) on apathy, loneliness, anxiety and activities of daily living in older people with Alzheimer's disease: randomized control study

Atay E, Bahadır Yılmaz E.

Aging Ment Health. 2025 May;29(5):897-905. doi: 10.1080/13607863.2024.2437060. Epub 2024 Dec 13.

Effects of an individual cognitive stimulation intervention on global cognition, memory, and executive function in older adults with mild to moderate Alzheimer's disease

Justo-Henriques SI, Pérez-Sáez E, Carvalho JO, Lemos R, Ribeiro Ó.

Clin Neuropsychol. 2025 Aug;39(6):1506-1524. doi: 10.1080/13854046.2024.2416568. Epub 2024 Oct 21.

NeuroEPO plus (NeuralCIM(®)) in Alzheimer's disease: Post-trial observational follow-up study

Sosa Pérez S, Urrutia Amable N, Viada González CE, Lorenzo-Luaces P, Sánchez Valdés L, Crombet Ramos T, León Monzón K, Rodríguez Obaya TJ, Pérez Ruiz L.

J Alzheimers Dis. 2025 Dec;108(3):1422-1435. doi: 10.1177/13872877251386885. Epub 2025 Oct 22.

Memory for Music (M4M) protocol for an international randomised controlled trial: effects of individual intensive musical training based on singing in non-musicians with Alzheimer's disease

Lichtensztejn M, Cui AX, Geretsegger M, Lundervold AJ, Koelsch S, Pfabigan DM, Assmus J, Langeland E, Ruiz M, Tabernig C, Skogseth RE, Gold C.

BMJ Open. 2025 Oct 20;15(10):e095136. doi: 10.1136/bmjopen-2024-095136.

The impact of music-based intervention on cognitive function and brain functional magnetic resonance imaging in people with mild Alzheimer's disease

Lyu J, Zhang W, De J, Shan B, Mao G, Jiang W, Rong X, Li W, Li M, Hu Y, Jia D, Gao W, Yang D.

J Alzheimers Dis. 2025 Nov;108(2):779-789. doi: 10.1177/13872877251379419. Epub 2025 Oct 3.

Impact of learning APOE genotype on cognitively unimpaired adults: a pre-screening cohort study of the Alzheimer's Prevention Initiative Generation Study 1

Langbaum JB, Bradbury AR, Egleston BL, McCarty Wood E, Langlois CM, Largent EA, Harkins K, Erickson CM, Stites SD, Oyen E, Riviere ME, Liu F, Graf A, Kim SYH, Grill JD, Reiman EM, Tariot PN, Roberts JS, Karlawish J.

Lancet Healthy Longev. 2025 Nov;6(11):100778. doi: 10.1016/j.lanhl.2025.100778. Epub 2025 Nov 27.

The effect of animal assisted rehabilitation practices on symptoms of Alzheimer's patients: systematic review and meta-analysis

Tüzün Özdemir S, Özer S.

Geriatr Nurs. 2025 May-Jun;63:521-527. doi: 10.1016/j.gerinurse.2025.03.045. Epub 2025 Apr 24.

Comparison of the efficacy of updated drugs for the treatment on the improvement of cognitive function in patients with Alzheimer 's disease: A systematic review and network meta- analysis

Cao W, Zhu B, Liu Z, Jia X, Zhao H, Gu N, Chang H, Xi J, Li R, Guo K, Shen J, Ding L, Sun F, Di Z.

Neuroscience. 2025 Jan 26;565:29-39. doi: 10.1016/j.neuroscience.2024.11.029. Epub 2024 Nov 15.

Detection of Alzheimer Disease in Neuroimages Using Vision Transformers: Systematic Review and Meta-Analysis

Mubonanyikuzo V, Yan H, Komolafe TE, Zhou L, Wu T, Wang N.

J Med Internet Res. 2025 Feb 5;27:e62647. doi: 10.2196/62647.

Alzheimer disease is (sometimes) highly heritable: Drivers of variation in heritability estimates for binary traits, a systematic review

Liu S, Bush WS, Akinyemi RO, Byrd GS, Caban-Holt AM, Rajabli F, Reitz C, Kunkle BW, Tosto G, Vance JM, Pericak-Vance M, Haines JL, Williams SM, Crawford DC.

PLoS Genet. 2025 Sep 4;21(9):e1011701. doi: 10.1371/journal.pgen.1011701. eCollection 2025 Sep.

Glutamatergic and GABAergic metabolite levels in Alzheimer's disease: a systematic review and meta-analysis

Ebrahimi R, Mohammad Soltani S, Masouri MM, Seifi M, Ghafourian K, Noori S.

BMC Neurol. 2025 Aug 26;25(1):344. doi: 10.1186/s12883-025-04375-2.

A multi-modal medical management and lifestyle intervention increase cerebral blood flow and lowers diabetic risk in persons with early Alzheimer's disease: Mid-trial results from the PREVENTION trial

Bramen JE, Siddarth P, Popa ES, Kress GT, Rapozo MK, Hodes JF, Ganapathi AS, Sparks WM, Tongson YM, Torres AM, Meysami S, Slyapich CB, Glatt RM, Pierce K, Miller KJ, Elhelou SH, Porter VR, Wong C, Kim M, Panos S, Hirsch DA, Raji CA, Bookheimer SY, Hood L, Roach JC, Merrill DA.

J Alzheimers Dis. 2025 Dec;108(4):1819-1833. doi: 10.1177/13872877251388933. Epub 2025 Nov 16.

Hippocampal Subfields Volume: Another Hint of the Continuum Between CAA and AD?

Storti B, Stanziano M, Marinoni G, Mazzè A, Francia A, Zacarias E, Strazzabosco C, De Toma C, Rifino N, Boncoraglio G, Di Fede G, Pollaci G, Gatti L, Canavero I, Bersano A.

Eur J Neurol. 2025 Jul;32(7):e70284. doi: 10.1111/ene.70284.

Therapeutic Efficacy of Autologous Blood-Derived Stem Cells with Growth Factors in Moderate to Severe Alzheimer's Disease: A Clinical Trial

Lee WJ, Cho K, Lee D, Lee S, Kim GW.

Mol Neurobiol. 2025 Dec 10;63(1):277. doi: 10.1007/s12035-025-05583-0.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias